Le Lézard
Classified in: Science and technology
Subjects: Conference, Event, Product/Service, Trade Show

Mitsubishi Electric Develops Behavioral-analysis AI that Analyzes Manual Tasks Without Requiring Training Data


Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it has developed a behavioral-analysis AI that analyzes the efficiency of manual tasks performed on production sites in just a few minutes without requiring operators to prepare AI-training data in advance, by adopting a probabilistic generative model. This new addition to the company's Maisart AI lineup quickly analyzes videos of people performing repetitive tasks and then visualizes how tasks can be performed more efficiently for greater productivity.

This is believed to be the world's first application of a probabilistic generative model that modeled cyclical (repetitive) physical actions performed during factory work. The technology, first announced by Mitsubishi Electric on February 13, 2019, has been shown in tests to reduce the time conventionally required for work analysis by up to 99%.

Commercialization is targeted for the fiscal year ending in March 2026, or later.

The technology will be exhibited and demonstrated at IIFES 2024 (Innovative Industry Fair for E x E Solutions 2024), which will be held at Tokyo Big Sight from January 31.

For the full text, please visit: www.MitsubishiElectric.com/news/


These press releases may also interest you

at 12:12
As the push for digital transformation accelerates within the public sector, it...

at 12:07
IGEL, provider of the secure endpoint OS for now and next, today announced winners of the IGEL Ready Partner of the Year Awards. The award winners were recognized today during the IGEL Ready Summit taking place this week at IGEL DIRUPT 24 in Miami,...

at 12:05
Rebellion Defense, the technology company building software to outpace national security threats, today announced it has been awarded a subcontract for Rebellion Nova to deliver continuous, automated testing for web applications hosted by the U.S....

at 12:05
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic...

at 12:05
Pharmaceutical Strategies Group ("PSG"), an EPIC company, released its annual Trends in Specialty Drug Benefits Report, co-sponsored by Genentech, a member of the Roche Group, detailing the complexities of specialty drug access and affordability. The...

at 12:05
DNB Markets ("DNB") and Back Bay Life Science Advisors ("Back Bay"), acting through the DNB//Back Bay Healthcare Partnership are pleased to announce the dates for our highly anticipated 9th annual Nordic-American Healthcare Conference (NAHC)....



News published on and distributed by: